aluates Reports

$ 0.0

Automative

Global Ophthalmic Corticosteroid Market Research Report 2026

Published Date: 2026-01-30

Report Code: QYRE-Auto-28B18195

Global Ophthalmic Corticosteroid Market Research Report 2024

BUY CHAPTERS

Global Ophthalmic Corticosteroid Market Research Report 2026

Code: QYRE-Auto-28B18195

Report

2026-01-30

Pages:118

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bausch and Lomb

Alimera Sciences

Allergan plc

Novartis

GlaxoSmithKline PLC

Genentech Inc

Pfizer Inc

Bayer

Regeneron Pharmaceuticals

Bausch Health

Ajanta Pharma

Sun Pharmaceutical

General Pharmaceuticals

Orchidia

Innovative Pharmaceuticals

Ophthalmic Corticosteroid Market

The global Ophthalmic Corticosteroid market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Ophthalmic corticosteroid is a type of medication specifically formulated for use in the eyes. It belongs to a class of drugs known as corticosteroids, which are synthetic versions of the natural hormones produced by the adrenal glands. These hormones have powerful anti-inflammatory and immune-suppressing properties.

The North American market for Ophthalmic Corticosteroid is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Ophthalmic Corticosteroid is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Ophthalmic Corticosteroid in Hospital Pharmacies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Ophthalmic Corticosteroid include Bausch and Lomb, Alimera Sciences, Allergan, Novartis AG, GlaxoSmithKline, Genentech, Pfizer, Bayer AG, Regeneron Pharmaceuticals, Bausch Health, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Ophthalmic Corticosteroid market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ophthalmic Corticosteroid. The Ophthalmic Corticosteroid market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Ophthalmic Corticosteroid market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Ophthalmic Corticosteroid manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Ophthalmic Corticosteroid Market Report

Report Metric	Details
Report Name	Ophthalmic Corticosteroid Market
Segment by Type	Difluprednate Loteprednol Dexamethasone Fluorometholone Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies Research Institute Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bausch and Lomb, Alimera Sciences, Allergan, Novartis AG, GlaxoSmithKline, Genentech, Pfizer, Bayer AG, Regeneron Pharmaceuticals, Bausch Health, Ajanta Pharma, Sun Pharmaceutical, General Pharmaceuticals, Orchidia, Innovative Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Ophthalmic Corticosteroid companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Ophthalmic Corticosteroid Market report?

Ans: The main players in the Ophthalmic Corticosteroid Market are Bausch and Lomb, Alimera Sciences, Allergan, Novartis AG, GlaxoSmithKline, Genentech, Pfizer, Bayer AG, Regeneron Pharmaceuticals, Bausch Health, Ajanta Pharma, Sun Pharmaceutical, General Pharmaceuticals, Orchidia, Innovative Pharmaceuticals

What are the Application segmentation covered in the Ophthalmic Corticosteroid Market report?

Ans: The Applications covered in the Ophthalmic Corticosteroid Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Research Institute, Others

What are the Type segmentation covered in the Ophthalmic Corticosteroid Market report?

Ans: The Types covered in the Ophthalmic Corticosteroid Market report are Difluprednate, Loteprednol, Dexamethasone, Fluorometholone, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ophthalmic Corticosteroid Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Difluprednate

1.2.3 Loteprednol

1.2.4 Dexamethasone

1.2.5 Fluorometholone

1.2.6 Others

1.3 Market by Application

1.3.1 Global Ophthalmic Corticosteroid Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.3.5 Research Institute

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ophthalmic Corticosteroid Market Perspective (2021–2032)

2.2 Global Ophthalmic Corticosteroid Growth Trends by Region

2.2.1 Global Ophthalmic Corticosteroid Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Ophthalmic Corticosteroid Historic Market Size by Region (2021–2026)

2.2.3 Ophthalmic Corticosteroid Forecasted Market Size by Region (2027–2032)

2.3 Ophthalmic Corticosteroid Market Dynamics

2.3.1 Ophthalmic Corticosteroid Industry Trends

2.3.2 Ophthalmic Corticosteroid Market Drivers

2.3.3 Ophthalmic Corticosteroid Market Challenges

2.3.4 Ophthalmic Corticosteroid Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ophthalmic Corticosteroid Players by Revenue

3.1.1 Global Top Ophthalmic Corticosteroid Players by Revenue (2021–2026)

3.1.2 Global Ophthalmic Corticosteroid Revenue Market Share by Players (2021–2026)

3.2 Global Top Ophthalmic Corticosteroid Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Ophthalmic Corticosteroid Revenue

3.4 Global Ophthalmic Corticosteroid Market Concentration Ratio

3.4.1 Global Ophthalmic Corticosteroid Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Corticosteroid Revenue in 2025

3.5 Global Key Players of Ophthalmic Corticosteroid Head Offices and Areas Served

3.6 Global Key Players of Ophthalmic Corticosteroid, Products and Applications

3.7 Global Key Players of Ophthalmic Corticosteroid, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Ophthalmic Corticosteroid Breakdown Data by Type

4.1 Global Ophthalmic Corticosteroid Historic Market Size by Type (2021–2026)

4.2 Global Ophthalmic Corticosteroid Forecasted Market Size by Type (2027–2032)

5 Ophthalmic Corticosteroid Breakdown Data by Application

5.1 Global Ophthalmic Corticosteroid Historic Market Size by Application (2021–2026)

5.2 Global Ophthalmic Corticosteroid Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Ophthalmic Corticosteroid Market Size (2021–2032)

6.2 North America Ophthalmic Corticosteroid Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Ophthalmic Corticosteroid Market Size by Country (2021–2026)

6.4 North America Ophthalmic Corticosteroid Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ophthalmic Corticosteroid Market Size (2021–2032)

7.2 Europe Ophthalmic Corticosteroid Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Ophthalmic Corticosteroid Market Size by Country (2021–2026)

7.4 Europe Ophthalmic Corticosteroid Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Ophthalmic Corticosteroid Market Size (2021–2032)

8.2 Asia-Pacific Ophthalmic Corticosteroid Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Ophthalmic Corticosteroid Market Size by Region (2021–2026)

8.4 Asia-Pacific Ophthalmic Corticosteroid Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Ophthalmic Corticosteroid Market Size (2021–2032)

9.2 Latin America Ophthalmic Corticosteroid Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Ophthalmic Corticosteroid Market Size by Country (2021–2026)

9.4 Latin America Ophthalmic Corticosteroid Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ophthalmic Corticosteroid Market Size (2021–2032)

10.2 Middle East & Africa Ophthalmic Corticosteroid Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2021–2026)

10.4 Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bausch and Lomb

11.1.1 Bausch and Lomb Company Details

11.1.2 Bausch and Lomb Business Overview

11.1.3 Bausch and Lomb Ophthalmic Corticosteroid Introduction

11.1.4 Bausch and Lomb Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.1.5 Bausch and Lomb Recent Development

11.2 Alimera Sciences

11.2.1 Alimera Sciences Company Details

11.2.2 Alimera Sciences Business Overview

11.2.3 Alimera Sciences Ophthalmic Corticosteroid Introduction

11.2.4 Alimera Sciences Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.2.5 Alimera Sciences Recent Development

11.3 Allergan

11.3.1 Allergan Company Details

11.3.2 Allergan Business Overview

11.3.3 Allergan Ophthalmic Corticosteroid Introduction

11.3.4 Allergan Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.3.5 Allergan Recent Development

11.4 Novartis AG

11.4.1 Novartis AG Company Details

11.4.2 Novartis AG Business Overview

11.4.3 Novartis AG Ophthalmic Corticosteroid Introduction

11.4.4 Novartis AG Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.4.5 Novartis AG Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Ophthalmic Corticosteroid Introduction

11.5.4 GlaxoSmithKline Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.5.5 GlaxoSmithKline Recent Development

11.6 Genentech

11.6.1 Genentech Company Details

11.6.2 Genentech Business Overview

11.6.3 Genentech Ophthalmic Corticosteroid Introduction

11.6.4 Genentech Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.6.5 Genentech Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Ophthalmic Corticosteroid Introduction

11.7.4 Pfizer Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.7.5 Pfizer Recent Development

11.8 Bayer AG

11.8.1 Bayer AG Company Details

11.8.2 Bayer AG Business Overview

11.8.3 Bayer AG Ophthalmic Corticosteroid Introduction

11.8.4 Bayer AG Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.8.5 Bayer AG Recent Development

11.9 Regeneron Pharmaceuticals

11.9.1 Regeneron Pharmaceuticals Company Details

11.9.2 Regeneron Pharmaceuticals Business Overview

11.9.3 Regeneron Pharmaceuticals Ophthalmic Corticosteroid Introduction

11.9.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.9.5 Regeneron Pharmaceuticals Recent Development

11.10 Bausch Health

11.10.1 Bausch Health Company Details

11.10.2 Bausch Health Business Overview

11.10.3 Bausch Health Ophthalmic Corticosteroid Introduction

11.10.4 Bausch Health Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.10.5 Bausch Health Recent Development

11.11 Ajanta Pharma

11.11.1 Ajanta Pharma Company Details

11.11.2 Ajanta Pharma Business Overview

11.11.3 Ajanta Pharma Ophthalmic Corticosteroid Introduction

11.11.4 Ajanta Pharma Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.11.5 Ajanta Pharma Recent Development

11.12 Sun Pharmaceutical

11.12.1 Sun Pharmaceutical Company Details

11.12.2 Sun Pharmaceutical Business Overview

11.12.3 Sun Pharmaceutical Ophthalmic Corticosteroid Introduction

11.12.4 Sun Pharmaceutical Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.12.5 Sun Pharmaceutical Recent Development

11.13 General Pharmaceuticals

11.13.1 General Pharmaceuticals Company Details

11.13.2 General Pharmaceuticals Business Overview

11.13.3 General Pharmaceuticals Ophthalmic Corticosteroid Introduction

11.13.4 General Pharmaceuticals Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.13.5 General Pharmaceuticals Recent Development

11.14 Orchidia

11.14.1 Orchidia Company Details

11.14.2 Orchidia Business Overview

11.14.3 Orchidia Ophthalmic Corticosteroid Introduction

11.14.4 Orchidia Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.14.5 Orchidia Recent Development

11.15 Innovative Pharmaceuticals

11.15.1 Innovative Pharmaceuticals Company Details

11.15.2 Innovative Pharmaceuticals Business Overview

11.15.3 Innovative Pharmaceuticals Ophthalmic Corticosteroid Introduction

11.15.4 Innovative Pharmaceuticals Revenue in Ophthalmic Corticosteroid Business (2021–2026)

11.15.5 Innovative Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bausch and Lomb

Alimera Sciences

Allergan plc

Novartis

GlaxoSmithKline PLC

Genentech Inc

Pfizer Inc

Bayer

Regeneron Pharmaceuticals

Bausch Health

Ajanta Pharma

Sun Pharmaceutical

General Pharmaceuticals

Orchidia

Innovative Pharmaceuticals

List of Tables

Table 1. Global Ophthalmic Corticosteroid Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Difluprednate

Table 3. Key Players of Loteprednol

Table 4. Key Players of Dexamethasone

Table 5. Key Players of Fluorometholone

Table 6. Key Players of Others

Table 7. Global Ophthalmic Corticosteroid Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Ophthalmic Corticosteroid Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Ophthalmic Corticosteroid Market Size by Region (US$ Million), 2021–2026

Table 10. Global Ophthalmic Corticosteroid Market Share by Region (2021–2026)

Table 11. Global Ophthalmic Corticosteroid Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Ophthalmic Corticosteroid Market Share by Region (2027–2032)

Table 13. Ophthalmic Corticosteroid Market Trends

Table 14. Ophthalmic Corticosteroid Market Drivers

Table 15. Ophthalmic Corticosteroid Market Challenges

Table 16. Ophthalmic Corticosteroid Market Restraints

Table 17. Global Ophthalmic Corticosteroid Revenue by Players (US$ Million), 2021–2026

Table 18. Global Ophthalmic Corticosteroid Market Share by Players (2021–2026)

Table 19. Global Top Ophthalmic Corticosteroid Players by Tier (Tier 1, Tier 2, and Tier 3), based on Ophthalmic Corticosteroid Revenue, 2025

Table 20. Ranking of Global Top Ophthalmic Corticosteroid Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Ophthalmic Corticosteroid Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Ophthalmic Corticosteroid, Headquarters and Area Served

Table 23. Global Key Players of Ophthalmic Corticosteroid, Products and Applications

Table 24. Global Key Players of Ophthalmic Corticosteroid, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Ophthalmic Corticosteroid Market Size by Type (US$ Million), 2021–2026

Table 27. Global Ophthalmic Corticosteroid Revenue Market Share by Type (2021–2026)

Table 28. Global Ophthalmic Corticosteroid Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Ophthalmic Corticosteroid Revenue Market Share by Type (2027–2032)

Table 30. Global Ophthalmic Corticosteroid Market Size by Application (US$ Million), 2021–2026

Table 31. Global Ophthalmic Corticosteroid Revenue Market Share by Application (2021–2026)

Table 32. Global Ophthalmic Corticosteroid Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Ophthalmic Corticosteroid Revenue Market Share by Application (2027–2032)

Table 34. North America Ophthalmic Corticosteroid Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Ophthalmic Corticosteroid Market Size by Country (US$ Million), 2021–2026

Table 36. North America Ophthalmic Corticosteroid Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Ophthalmic Corticosteroid Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Ophthalmic Corticosteroid Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Ophthalmic Corticosteroid Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Ophthalmic Corticosteroid Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Ophthalmic Corticosteroid Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Ophthalmic Corticosteroid Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Ophthalmic Corticosteroid Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Ophthalmic Corticosteroid Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Ophthalmic Corticosteroid Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Ophthalmic Corticosteroid Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (US$ Million), 2027–2032

Table 49. Bausch and Lomb Company Details

Table 50. Bausch and Lomb Business Overview

Table 51. Bausch and Lomb Ophthalmic Corticosteroid Product

Table 52. Bausch and Lomb Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 53. Bausch and Lomb Recent Development

Table 54. Alimera Sciences Company Details

Table 55. Alimera Sciences Business Overview

Table 56. Alimera Sciences Ophthalmic Corticosteroid Product

Table 57. Alimera Sciences Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 58. Alimera Sciences Recent Development

Table 59. Allergan Company Details

Table 60. Allergan Business Overview

Table 61. Allergan Ophthalmic Corticosteroid Product

Table 62. Allergan Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 63. Allergan Recent Development

Table 64. Novartis AG Company Details

Table 65. Novartis AG Business Overview

Table 66. Novartis AG Ophthalmic Corticosteroid Product

Table 67. Novartis AG Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 68. Novartis AG Recent Development

Table 69. GlaxoSmithKline Company Details

Table 70. GlaxoSmithKline Business Overview

Table 71. GlaxoSmithKline Ophthalmic Corticosteroid Product

Table 72. GlaxoSmithKline Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 73. GlaxoSmithKline Recent Development

Table 74. Genentech Company Details

Table 75. Genentech Business Overview

Table 76. Genentech Ophthalmic Corticosteroid Product

Table 77. Genentech Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 78. Genentech Recent Development

Table 79. Pfizer Company Details

Table 80. Pfizer Business Overview

Table 81. Pfizer Ophthalmic Corticosteroid Product

Table 82. Pfizer Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 83. Pfizer Recent Development

Table 84. Bayer AG Company Details

Table 85. Bayer AG Business Overview

Table 86. Bayer AG Ophthalmic Corticosteroid Product

Table 87. Bayer AG Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 88. Bayer AG Recent Development

Table 89. Regeneron Pharmaceuticals Company Details

Table 90. Regeneron Pharmaceuticals Business Overview

Table 91. Regeneron Pharmaceuticals Ophthalmic Corticosteroid Product

Table 92. Regeneron Pharmaceuticals Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 93. Regeneron Pharmaceuticals Recent Development

Table 94. Bausch Health Company Details

Table 95. Bausch Health Business Overview

Table 96. Bausch Health Ophthalmic Corticosteroid Product

Table 97. Bausch Health Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 98. Bausch Health Recent Development

Table 99. Ajanta Pharma Company Details

Table 100. Ajanta Pharma Business Overview

Table 101. Ajanta Pharma Ophthalmic Corticosteroid Product

Table 102. Ajanta Pharma Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 103. Ajanta Pharma Recent Development

Table 104. Sun Pharmaceutical Company Details

Table 105. Sun Pharmaceutical Business Overview

Table 106. Sun Pharmaceutical Ophthalmic Corticosteroid Product

Table 107. Sun Pharmaceutical Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 108. Sun Pharmaceutical Recent Development

Table 109. General Pharmaceuticals Company Details

Table 110. General Pharmaceuticals Business Overview

Table 111. General Pharmaceuticals Ophthalmic Corticosteroid Product

Table 112. General Pharmaceuticals Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 113. General Pharmaceuticals Recent Development

Table 114. Orchidia Company Details

Table 115. Orchidia Business Overview

Table 116. Orchidia Ophthalmic Corticosteroid Product

Table 117. Orchidia Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 118. Orchidia Recent Development

Table 119. Innovative Pharmaceuticals Company Details

Table 120. Innovative Pharmaceuticals Business Overview

Table 121. Innovative Pharmaceuticals Ophthalmic Corticosteroid Product

Table 122. Innovative Pharmaceuticals Revenue in Ophthalmic Corticosteroid Business (US$ Million), 2021–2026

Table 123. Innovative Pharmaceuticals Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

Table 127. Authors List of This Report

List of Figures

Figure 1. Ophthalmic Corticosteroid Picture

Figure 2. Global Ophthalmic Corticosteroid Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Ophthalmic Corticosteroid Market Share by Type: 2025 vs 2032

Figure 4. Difluprednate Features

Figure 5. Loteprednol Features

Figure 6. Dexamethasone Features

Figure 7. Fluorometholone Features

Figure 8. Others Features

Figure 9. Global Ophthalmic Corticosteroid Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Ophthalmic Corticosteroid Market Share by Application: 2025 vs 2032

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Online Pharmacies Case Studies

Figure 14. Research Institute Case Studies

Figure 15. Others Case Studies

Figure 16. Ophthalmic Corticosteroid Report Years Considered

Figure 17. Global Ophthalmic Corticosteroid Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 18. Global Ophthalmic Corticosteroid Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Ophthalmic Corticosteroid Market Share by Region: 2025 vs 2032

Figure 20. Global Ophthalmic Corticosteroid Market Share by Players in 2025

Figure 21. Global Ophthalmic Corticosteroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Ophthalmic Corticosteroid Revenue in 2025

Figure 23. North America Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. North America Ophthalmic Corticosteroid Market Share by Country (2021–2032)

Figure 25. United States Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Canada Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Ophthalmic Corticosteroid Market Share by Country (2021–2032)

Figure 29. Germany Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. France Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. U.K. Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Italy Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Russia Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Ireland Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Ophthalmic Corticosteroid Market Share by Region (2021–2032)

Figure 37. China Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Japan Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. South Korea Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Southeast Asia Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. India Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Australia & New Zealand Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Ophthalmic Corticosteroid Market Share by Country (2021–2032)

Figure 45. Mexico Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Brazil Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Ophthalmic Corticosteroid Market Share by Country (2021–2032)

Figure 49. Israel Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Saudi Arabia Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. UAE Ophthalmic Corticosteroid Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Bausch and Lomb Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 53. Alimera Sciences Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 54. Allergan Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 55. Novartis AG Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 56. GlaxoSmithKline Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 57. Genentech Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 58. Pfizer Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 59. Bayer AG Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 61. Bausch Health Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 62. Ajanta Pharma Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 63. Sun Pharmaceutical Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 64. General Pharmaceuticals Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 65. Orchidia Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 66. Innovative Pharmaceuticals Revenue Growth Rate in Ophthalmic Corticosteroid Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Ophthalmic Steroids Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Corticosteroid Medication Market Research Report 2024

Steroid Corticosteroids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Loteprednol Etabonate Ophthalmic Drugs Market Research Report 2024

Iritis Ophthalmic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Corticosteroids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intranasal Corticosteroids Market Research Report 2024

Global Hydrocortisone Acetate Preparations Market Research Report 2024

Global Glucocorticoid Injection Market Research Report 2024

Corticosteroids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dexamethasone Implant Market Research Report 2024

Global Blepharitis Steroids Treatment Market Research Report 2025

Global Corticosteroids API Market Research Report 2025

Global Corticosteroid API Market Research Report 2025

Global Fluorometholone Market Research Report 2024

Global Cortisone Market Research Report 2024

Global Steroids for Pets Market Research Report 2025

Global Adrenal Corticosteroid Inhibitors Market Research Report 2024

Ophthalmic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions